Neonatal cholestasis is a condition that affects newborn babies, caused by a blockage of bile flow from the liver to the intestines. It is characterized by itching skin, yellowish staining of the skin and whites of the eyes, and dark urine. In most cases, the condition will resolve itself and the baby will not suffer long-term effects. However, if left untreated, neonatal cholestasis can result in serious liver damage, jaundice, malnutrition, and even death. Neonatal cholestasis is most often caused by a genetic disorder, such as alpha-1 antitrypsin deficiency, Dubin-Johnson syndrome, or a bile acid synthesis defect. These genetic disorders can be inherited, or can occur spontaneously in the baby due to a mutation in the genes. In some cases, the cause of the condition can also be due to an infection, a medication taken by the mother during pregnancy, or a complication of another condition such as cystic fibrosis. Diagnosis of neonatal cholestasis is usually done through a combination of blood tests and imaging studies. The blood tests measure the levels of bile acids in the blood, which are elevated in cases of neonatal cholestasis. Imaging studies, such as ultrasound or magnetic resonance imaging (MRI), can help to identify any obstruction of the bile ducts. Treatment of neonatal cholestasis is typically done with medication to help relieve the symptoms and prevent further damage to the liver. These medications include ursodeoxycholic acid, which helps to reduce bile acid levels and reduce the itching, as well as vitamin K supplementation to help prevent bleeding. If the cause of the condition is an infection, antibiotics may be prescribed. Surgery may be necessary if the blockage is due to a physical obstruction of the bile duct. Neonatal cholestasis is a serious condition that can have long-term implications, including liver damage and malnutrition. It is important to diagnose and treat the condition early to help prevent long-term complications. It is also important for parents to seek out genetic counseling if the condition is hereditary.
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Nanoemulsions as a strategy to enhance gastrointestinal bioavailability and bioactivity of lipid based nutraceuticals
Pubali Dhar, University of Calcutta, India
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : Sickle cell liver disease: A multidisciplinary hemato-hepatology approach
Bandar Aljudaibi, King Faisal Specialists Hospital and Research Centre, Saudi Arabia
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, Department of Public Health of Romagna, Italy